SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF A CLC-1 INHIBITOR - A FIRST-IN-CLASS COMPOUND THAT ENHANCES MUSCLE EXCITABILITY: A PHASE I, SINGLE- AND MULTIPLE-ASCENDING DOSE STUDY

Titia Q. Ruijs, Catherine M.K.E. de Cuba, Jules A.A.C. Heuberger, John Hutchison, Jane Bold, Thomas S. Grønnebæk, Klaus G Jensen, Eva Chin, Jorge A. Quiroz, Thomas K. Petersen, Peter Flagstad, Marieke L. de Kam, Michiel J. van Esdonk, Erica Klaassen, Robert J. Doll, Ingrid W. Koopmans, Annika A. de Goede, Thomas H. Pedersen, Geert Jan Groeneveld
doi: https://doi.org/10.1101/2024.02.15.24302858

Article usage

Article usage: February 2024 to June 2025

AbstractFullPdf
Feb 2024204938
Mar 2024135528
Apr 202479523
May 202463714
Jun 202455713
Jul 202444219
Aug 2024501128
Sep 202437513
Oct 202432511
Nov 202448017
Dec 202456515
Jan 202550310
Feb 2025321217
Mar 2025341820
Apr 202542726
May 202544540
Jun 2025906
Back to top
Posted February 17, 2024.
Download PDF

Supplementary Material

Data/Code
Email
SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF A CLC-1 INHIBITOR - A FIRST-IN-CLASS COMPOUND THAT ENHANCES MUSCLE EXCITABILITY: A PHASE I, SINGLE- AND MULTIPLE-ASCENDING DOSE STUDY
Titia Q. Ruijs, Catherine M.K.E. de Cuba, Jules A.A.C. Heuberger, John Hutchison, Jane Bold, Thomas S. Grønnebæk, Klaus G Jensen, Eva Chin, Jorge A. Quiroz, Thomas K. Petersen, Peter Flagstad, Marieke L. de Kam, Michiel J. van Esdonk, Erica Klaassen, Robert J. Doll, Ingrid W. Koopmans, Annika A. de Goede, Thomas H. Pedersen, Geert Jan Groeneveld
medRxiv 2024.02.15.24302858; doi: https://doi.org/10.1101/2024.02.15.24302858
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area